心肌梗死患者C_(3b)受体和红细胞免疫复合物受体变化  

Change of erythrocyte C_(3b) receptor and erythrocyte immunity complex receptor in the AMI patients

作　　者：王志华[1] 王春梅 

机构地区：[1]上海市闸北区中心医院心内科,上海200070 [2]上海市仁和医院,上海200431

出　　处：《海南医学》2004年第9期52-53,共2页Hainan Medical Journal

摘　　要：目的　观察急性心肌梗死患者溶栓治疗前后红细胞C3b受体 (RBC -C3bR)及红细胞免疫复合物受体(RBC -ICR)的变化。方法　与健康对照组相比 ,观察急性心肌梗死患者应用rt-PA治疗前后RBC -C3bR及RBC -ICR的变化。结果　心肌梗死急性期RBC -C3bR明显减低 (p <0 .0 1) ,RBC -ICR增高 (p <0 .0 1) ;经rt-PA治疗后14天后 ,上述免疫紊乱有所恢复。结论　急性心肌梗死患者红细胞免疫粘附功能异常 ;应用rt-PA溶栓治疗后可得到改善。Objective To observe the changes of erythrocyte c 3b receptor(REC-C 3b R) and erythrocyte immunity complex receptor(REC-ICR) in the patients of acute myocardial infarction(AMI)before and after the thrombolytic therapy.Methods Compare REC-C 3b , and RBC-ICR of the 30 AMI patients before and after treatment of rt-PA,while 30 healthy volunteers as a control group.Results RBC-C 3b R in AMI is low significantly(p<0. 01), RBC-ICR increased significantly (p<0.01);the immunity disorder had changed into normal after the treatment with rt-PA.Conclusions Erythrocyte immunity adherence function is abnormal in the patients of AMI; Abnormal above can be changed by rt-PA thrombolytic therapy.

关 键 词：心肌梗死 红细胞C3B受体 红细胞免疫复合物受体 

分 类 号：R542.22[医药卫生—心血管疾病]